Segui
Alessandro Granito
Alessandro Granito
Associate Professor Dep. of Medical and Surgical Sciences, University of Bologna, IRCCS S.Orsola
Email verificata su unibo.it - Home page
Titolo
Citata da
Citata da
Anno
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
J Bruix, S Qin, P Merle, A Granito, YH Huang, G Bodoky, M Pracht, ...
The Lancet 389 (10064), 56-66, 2017
34332017
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study
F Piscaglia, G Svegliati‐Baroni, A Barchetti, A Pecorelli, S Marinelli, ...
Hepatology 63 (3), 827-838, 2016
5802016
Field‐practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy
M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ...
Hepatology 54 (6), 2055-2063, 2011
4182011
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial
RS Finn, P Merle, A Granito, YH Huang, G Bodoky, M Pracht, O Yokosuka, ...
Journal of Hepatology 69 (2), 353-358, 2018
3392018
Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study
P Collin, K Kaukinen, H Vogelsang, I Korponay-Szabó, R Sommer, ...
European Journal of Gastroenterology & Hepatology 17 (1), 85-91, 2005
3012005
Autoimmune hepatitis–current management and challenges
K Zachou, P Muratori, GK Koukoulis, A Granito, N Gatselis, A Fabbri, ...
Alimentary Pharmacology & Therapeutics 38 (8), 887-913, 2013
2382013
High prevalence of celiac disease in Italian general population
U Volta, S Bellentani, FB Bianchi, G Brandi, L De Franceschi, L Miglioli, ...
Digestive Diseases and Sciences 46 (7), 1500-1505, 2001
2302001
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis
S Ferri, MS Longhi, C De Molo, C Lalanne, P Muratori, A Granito, ...
Hepatology 52 (3), 999-1007, 2010
2192010
Celiac disease in autoimmune cholestatic liver disorders
U Volta, L Rodrigo, A Granito, N Petrolini, P Muratori, L Muratori, ...
American Journal of Gastroenterology 97 (10), 2609-2613, 2002
2112002
Contrast Ultrasound LI-RADS LR-5 Identifies Hepatocellular Carcinoma in Cirrhosis in a Multicenter Restropective Study of 1,006 Nodules
E Terzi, M Iavarone, M Pompili, L Veronese, G Cabibbo, M Fraquelli, ...
Journal of Hepatology 68 (3), 485-492, 2018
2092018
Autoimmune hepatitis in Italy: the Bologna experience
P Muratori, A Granito, C Quarneti, S Ferri, R Menichella, F Cassani, ...
Journal of Hepatology 50 (6), 1210-1218, 2009
1712009
RESORCE Investigators Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled …
J Bruix, S Qin, P Merle, A Granito, YH Huang, G Bodoky, M Pracht, ...
Lancet 389 (10064), 56-66, 2017
1662017
Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up
U Volta, A Granito, E Fiorini, C Parisi, M Piscaglia, G Pappas, P Muratori, ...
Digestive Diseases and Sciences 53 (6), 1582-1588, 2008
1612008
COVID‐19 and immunological dysregulation: can autoantibodies be useful?
S Pascolini, A Vannini, G Deleonardi, M Ciordinik, A Sensoli, I Carletti, ...
Clinical and translational science 14 (2), 502-508, 2021
1572021
Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis
U Volta, A Granito, C Parisi, A Fabbri, E Fiorini, M Piscaglia, F Tovoli, ...
Journal of Clinical Gastroenterology 44 (3), 186-190, 2010
1562010
New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm
M Renzulli, M Biselli, S Brocchi, A Granito, F Vasuri, F Tovoli, ...
Gut 67 (9), 1674-1682, 2018
1532018
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE‐1 study
M Scartozzi, L Faloppi, G Svegliati Baroni, C Loretelli, F Piscaglia, ...
International Journal of Cancer 135 (5), 1247-1256, 2014
1432014
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome
P Muratori, A Granito, G Pappas, GM Pendino, C Quarneti, R Cicola, ...
Official journal of the American College of Gastroenterology| ACG 104 (6 …, 2009
1432009
Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis
A Granito, L Bolondi
The Lancet Oncology 18 (2), e101-e112, 2017
1342017
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound
M Galassi, M Iavarone, S Rossi, S Bota, S Vavassori, L Rosa, S Leoni, ...
Liver International 33 (5), 771-779, 2013
1322013
Il sistema al momento non puň eseguire l'operazione. Riprova piů tardi.
Articoli 1–20